Total Payments
$101,034
2024 Payments
$1,169
Companies
53
Transactions
670
Medicare Patients
9,275
Medicare Billing
$1.7M
Payment Breakdown by Category
Other$75,305 (74.5%)
Food & Beverage$11,607 (11.5%)
Education$9,833 (9.7%)
Travel$4,290 (4.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,305 | 45 | 74.5% |
| Food and Beverage | $11,607 | 583 | 11.5% |
| Education | $9,833 | 21 | 9.7% |
| Travel and Lodging | $4,290 | 21 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $81,744 | 148 | $0 (2024) |
| AngioDynamics, Inc. | $9,600 | 4 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,715 | 119 | $0 (2024) |
| Boston Scientific Corporation | $1,288 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $860.79 | 54 | $0 (2024) |
| PFIZER INC. | $848.05 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $785.28 | 47 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $497.36 | 47 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $375.10 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $361.41 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,169 | 62 | PFIZER INC. ($311.52) |
| 2023 | $8,472 | 85 | Amgen Inc. ($7,080) |
| 2022 | $8,751 | 88 | Amgen Inc. ($7,247) |
| 2021 | $10,061 | 73 | Amgen Inc. ($8,825) |
| 2020 | $14,575 | 61 | Amgen Inc. ($11,610) |
| 2019 | $11,759 | 111 | Amgen Inc. ($8,173) |
| 2018 | $38,283 | 100 | Amgen Inc. ($35,111) |
| 2017 | $7,963 | 90 | Amgen Inc. ($3,636) |
All Payment Transactions
670 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 11/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.23 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $27.37 | General |
| Category: Cardiovascular | ||||||
| 09/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.91 | General |
| Category: Cardiovascular | ||||||
| 08/06/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $58.24 | General |
| Category: Cardiovascular Device | ||||||
| 08/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/26/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: WATCHMAN_IC | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,098 | 3,304 | $1.0M | $367,420 |
| 2022 | 28 | 2,388 | 7,248 | $1.2M | $474,188 |
| 2021 | 26 | 2,534 | 3,780 | $1.2M | $456,994 |
| 2020 | 25 | 2,255 | 3,377 | $1.1M | $405,907 |
Total Patients
9,275
Total Services
17,709
Medicare Billing
$1.7M
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 104 | 104 | $228,800 | $112,797 | 49.3% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 104 | 208 | $145,600 | $84,237 | 57.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 457 | 778 | $198,150 | $67,129 | 33.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 139 | 144 | $100,800 | $20,705 | 20.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 111 | 444 | $35,964 | $18,091 | 50.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $37,126 | $10,805 | 29.1% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 100 | 100 | $50,000 | $10,161 | 20.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 112 | 115 | $29,900 | $5,610 | 18.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 11 | 88 | $9,680 | $4,611 | 47.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 24 | 25 | $55,895 | $4,241 | 7.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 64 | $12,190 | $3,536 | 29.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 68 | 69 | $15,525 | $3,515 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 28 | $10,570 | $3,473 | 32.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 37 | 62 | $11,602 | $3,317 | 28.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 296 | 308 | $13,976 | $2,974 | 21.3% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 63 | 176 | $15,312 | $2,818 | 18.4% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 87 | 88 | $22,000 | $2,535 | 11.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 40 | 108 | $10,476 | $2,317 | 22.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 11 | 88 | $7,656 | $1,781 | 23.3% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 24 | 68 | $13,056 | $1,743 | 13.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 90 | 110 | $4,510 | $670.68 | 14.9% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 14 | 14 | $916.00 | $243.24 | 26.6% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 14 | 14 | $518.00 | $112.32 | 21.7% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 126 | 126 | $277,200 | $139,124 | 50.2% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2022 | 126 | 249 | $174,300 | $102,911 | 59.0% |
About Dr. Kevin Thompson, DO
Dr. Kevin Thompson, DO is a Cardiovascular Disease healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164587119.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Thompson, DO has received a total of $101,034 in payments from pharmaceutical and medical device companies, with $1,169 received in 2024. These payments were reported across 670 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,305).
As a Medicare-enrolled provider, Thompson has provided services to 9,275 Medicare beneficiaries, totaling 17,709 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology, Interventional Cardiology
- Location Salem, OR
- Active Since 12/27/2006
- Last Updated 07/11/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1164587119
Products in Payments
- Repatha (Biological) $81,331
- EVLT (Device) $9,600
- ENTRESTO (Drug) $1,380
- ELIQUIS (Drug) $1,281
- GENERAL - VASCULAR ACCESS (Device) $1,006
- XARELTO (Drug) $497.36
- Corlanor (Drug) $395.17
- BRILINTA (Drug) $385.63
- VERQUVO (Drug) $361.41
- LEQVIO (Drug) $335.55
- JARDIANCE (Drug) $291.45
- Impella (Device) $269.32
- Vascepa (Drug) $248.01
- CAMZYOS (Drug) $224.07
- FARXIGA (Drug) $215.97
- LifeVest (Device) $212.65
- VYNDAQEL (Drug) $196.73
- SYMBICORT (Drug) $171.80
- NEXLETOL (Drug) $161.52
- WATCHMAN Access System (Device) $142.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Salem
Ashit Patel, M.d, M.D
Cardiovascular Disease — Payments: $54,451
Cardiovascular Disease $54,451
Dr. Sandeep Saha, M.d, M.D
Cardiovascular Disease — Payments: $43,942
Cardiovascular Disease $43,942
Dr. Andrew Maiolo, Md, MD
Cardiovascular Disease — Payments: $19,968
Cardiovascular Disease $19,968
Maziar Azadpour, M.d, M.D
Cardiovascular Disease — Payments: $17,622
Cardiovascular Disease $17,622
Barath Krishnamurthy, Md, MD
Cardiovascular Disease — Payments: $13,695
Cardiovascular Disease $13,695
Deborah Hughes, M.d, M.D
Cardiovascular Disease — Payments: $10,535
Cardiovascular Disease $10,535